Drug patents …
… from Kazakhstan to Kalamazoo
Anticipate generic drug launch
Deep knowledge on
small-molecule drugs and
the 110,000 global patents
Proactively manage your pharmacy inventory
Manage your formulary budget
Find generic entry opportunities
Flat-rate pricing for predictable budgeting
Short-term plans for project- or client-based billing
|Title:||Polypeptide compound and a process for preparation thereof|
|Abstract:||A polypeptide compound having antimicrobial activity of the following general formula: ##STR1## wherein R.sup.1 is hydrogen or acyl group, R.sup.2 is hydroxy or acyloxy, R.sup.3 is hydroxysulfonyloxy, and R.sup.4 is hydrogen or carbamoyl, with proviso that R.sup.1 is not palmitoyl, when R.sup.2 is hydroxy, R.sup.3 is hydroxysulfonyloxy and R.sup.4 is carbamoyl, and a pharmaceutically acceptable salt thereof.|
|Inventor(s):||Iwamoto; Toshiro (Tsukuba, JP), Fujie; Akihiko (Tsuchiura, JP), Nitta; Kumiko (Tsuchiura, JP), Tsurumi; Yasuhisa (Tsukuba, JP), Shigematsu; Nobuharu (Tsukuba, JP), Kasahara; Chiyoshi (Ikeda, JP), Hino; Motohiro (Tsuchiura, JP), Okuhara; Masakuni (Tsukuba, JP), Sakane; Kazuo (Kawanishi, JP), Kawabata; Kohji (Kawanishi, JP), Ohki; Hidenori (Ikeda, JP)|
|Assignee:||Fujisawa Pharmaceutical Co., Ltd. (Osaka, JP)|
Patent Claim Types:|
see list of patent claims
|Country||Document Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
|United Kingdom||9013558||<disabled in preview>|
|Canada||2044746||<disabled in preview>|
|China||1059729||<disabled in preview>|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.